Alpha 2.0
Login Register
» Authors » Nobuyoshi Nishiyama

Nobuyoshi Nishiyama

Explore the profile of Nobuyoshi Nishiyama including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 35
Citations 602
Followers 0
Related Specialties
Neurology
Pharmacology
Biochemistry
Top 10 Co-Authors
Norio Matsuki
Yuji Ikegaya
Maki K Yamada
Koh-Ichi Tanaka
Nobue Kitanaka
Junichi Kitanaka
F Scott Hall
George R Uhl
Motohiko Takemura
Ryuta Koyama
Published In
Brain Res
Eur J Neurosci
J Neurosci
Cereb Cortex
Pharmacol Biochem Behav
Affiliations
Soon will be listed here.
Recent Articles
1.
Are Histamine H Antagonists the Definitive Treatment for Acute Methamphetamine Intoxication?
Kitanaka N, Hall F, Tanaka K, Tomita K, Igarashi K, Nishiyama N, et al.
Curr Drug Res Rev . 2022 Apr; 14(3):162-170. PMID: 35431009
Background: Methamphetamine (METH) is classified as a Schedule II stimulant drug under the United Nations Convention on Psychotropic Substances of 1971. METH and other amphetamine analogues (AMPHs) are powerful addictive...
2.
Metoprine, a histamine N-methyltransferase inhibitor, attenuates methamphetamine-induced hyperlocomotion via activation of histaminergic neurotransmission in mice
Kitanaka N, Hall F, Kobori S, Kushihara S, Oyama H, Sasaoka Y, et al.
Pharmacol Biochem Behav . 2021 Aug; 209:173257. PMID: 34418452
Metoprine increases the content of histamine in brain by inhibiting histamine N-methyltransferase (HMT), a centrally acting histamine degrading enzyme. We present data demonstrating that pretreatment with metoprine attenuates the hyperlocomotive...
3.
Elevated H2 O2 levels in trinitrobenzene sulfate-induced colitis rats contributes to visceral hyperalgesia through interaction with the transient receptor potential ankyrin 1 cation channel
Kogure Y, Wang S, Tanaka K, Hao Y, Yamamoto S, Nishiyama N, et al.
J Gastroenterol Hepatol . 2015 Nov; 31(6):1147-53. PMID: 26574143
Background And Aim: Inflammatory bowel disease is associated with chronic abdominal pain. Transient receptor potential ankyrin 1 (TRPA1) is a well-known pain sensor expressed in primary sensory neurons. Recent studies...
4.
Memory impairment and reduced exploratory behavior in mice after administration of systemic morphine
Kitanaka J, Kitanaka N, Hall F, Fujii M, Goto A, Kanda Y, et al.
J Exp Neurosci . 2015 May; 9:27-35. PMID: 25987850
In the present study, the effects of morphine were examined on tests of spatial memory, object exploration, locomotion, and anxiety in male ICR mice. Administration of morphine (15 or 30...
5.
Agmatine attenuates methamphetamine-induced hyperlocomotion and stereotyped behavior in mice
Kitanaka N, Kitanaka J, Hall F, Uhl G, Watabe K, Kubo H, et al.
Behav Pharmacol . 2014 Feb; 25(2):158-65. PMID: 24557322
We investigated whether pretreatment with the neurotransmitter/neuromodulator agmatine (decarboxylated L-arginine) affected methamphetamine (METH)-induced hyperlocomotion and stereotypy in male ICR mice. Agmatine pretreatment alone had no effects on locomotion or stereotypy,...
6.
The selective μ opioid receptor antagonist β-funaltrexamine attenuates methamphetamine-induced stereotypical biting in mice
Kitanaka J, Kitanaka N, Hall F, Uhl G, Fukushima Y, Sawai T, et al.
Brain Res . 2013 Jun; 1522:88-98. PMID: 23727404
We investigated whether pretreatment with opioid receptor antagonists affected methamphetamine (METH)-induced stereotypy in mice. Pretreatment of male ICR mice with naloxone, a relatively non-selective opioid receptor antagonist, significantly attenuated the...
7.
Straub tail reaction in mice treated with σ(1) receptor antagonist in combination with methamphetamine
Kitanaka J, Kitanaka N, Hall F, Uhl G, Tanaka K, Nishiyama N, et al.
Brain Res . 2012 Sep; 1482:40-6. PMID: 22981417
Straub tail reaction (STR) was observed in male ddY mice after simultaneous administration with BMY 14802 (a non-specific σ receptor antagonist) and methamphetamine (METH). The intensity and duration of STR...
8.
Pretreatment with nomifensine or nomifensine analogue 4-phenyl-1,2,3,4-tetrahydroisoquinoline augments methamphetamine-induced stereotypical behavior in mice
Kitanaka J, Kitanaka N, Hall F, Uhl G, Asano H, Chatani R, et al.
Brain Res . 2012 Jan; 1439:15-26. PMID: 22265332
Nomifensine is a dopamine/norepinephrine reuptake inhibitor. Nomifensine and some of its structural analogues produce behavioral effects indicative of indirect dopaminergic agonist properties, such as hyperlocomotion. By contrast, the deaminated and...
9.
Histamine H3 receptor agonists decrease hypothalamic histamine levels and increase stereotypical biting in mice challenged with methamphetamine
Kitanaka J, Kitanaka N, Hall F, Uhl G, Tatsuta T, Morita Y, et al.
Neurochem Res . 2011 May; 36(10):1824-33. PMID: 21573995
The effects of the histamine H(3) receptor agonists (R)-α-methylhistamine, imetit and immepip on methamphetamine (METH)-induced stereotypical behavior were examined in mice. The administration of METH (10 mg/kg, i.p.) to male...
10.
Withdrawal from fixed-dose injection of methamphetamine decreases cerebral levels of 3-methoxy-4-hydroxyphenylglycol and induces the expression of anxiety-related behavior in mice
Kitanaka N, Kitanaka J, Tatsuta T, Tanaka K, Watabe K, Nishiyama N, et al.
Neurochem Res . 2010 Feb; 35(5):749-60. PMID: 20148307
A variety of drug treatment regimens have been proposed to model the dysphoric state observed during methamphetamine (METH) withdrawal in rats, but little has been established in experiments using mice....